Suppr超能文献

独特的E2F介导的转录程序调控p14ARF基因表达。

Distinct E2F-mediated transcriptional program regulates p14ARF gene expression.

作者信息

Komori Hideyuki, Enomoto Mitsuru, Nakamura Masataka, Iwanaga Ritsuko, Ohtani Kiyoshi

机构信息

Human Gene Sciences Center, Tokyo Medical and Dental University, Yushima, Bunkyo-ku, Tokyo, Japan.

出版信息

EMBO J. 2005 Nov 2;24(21):3724-36. doi: 10.1038/sj.emboj.7600836. Epub 2005 Oct 6.

Abstract

The tumor suppressor p14(ARF) gene is induced by ectopically expressed E2F, a positive regulator of the cell cycle. The gene is expressed at low levels in normally growing cells in contrast to high levels in varieties of tumors. How p14(ARF) gene is regulated by E2F in normally growing cells and tumor cells remains obscure. Here we show that regulation of p14(ARF) gene by E2F is distinct from that of classical E2F targets. It is directly mediated by E2F through a novel E2F-responsive element that varies from the typical E2F site. The element responds to E2F activity resulting from ectopic E2F1 expression, inactivation of pRb by adenovirus E1a or shRNA, but not to phosphorylation of pRb by serum stimulation or ectopic cyclin D1/cyclin-dependent kinase-4 expression in normal human fibroblasts. The element has activity in various tumor cells with defective pRb, but not in normally growing cells. These results indicate that the distinct regulation constitutes the basis of p14(ARF) function as a tumor suppressor, discriminating abnormal growth signals caused by defects in pRb function from normal growth signals.

摘要

肿瘤抑制因子p14(ARF)基因由异位表达的E2F诱导产生,E2F是细胞周期的正调控因子。与多种肿瘤细胞中该基因的高表达相反,它在正常生长的细胞中低水平表达。在正常生长的细胞和肿瘤细胞中,E2F如何调控p14(ARF)基因仍不清楚。在此我们表明,E2F对p14(ARF)基因的调控不同于经典的E2F靶标。它由E2F通过一个新型的E2F反应元件直接介导,该元件不同于典型的E2F位点。在正常人成纤维细胞中,该元件对异位表达E2F1、腺病毒E1a或短发夹RNA使pRb失活所产生的E2F活性有反应,但对血清刺激导致的pRb磷酸化或异位表达细胞周期蛋白D1/细胞周期蛋白依赖性激酶4没有反应。该元件在各种pRb功能缺陷的肿瘤细胞中有活性,但在正常生长的细胞中没有活性。这些结果表明,这种独特的调控构成了p14(ARF)作为肿瘤抑制因子发挥功能的基础,将由pRb功能缺陷引起的异常生长信号与正常生长信号区分开来。

相似文献

1
Distinct E2F-mediated transcriptional program regulates p14ARF gene expression.
EMBO J. 2005 Nov 2;24(21):3724-36. doi: 10.1038/sj.emboj.7600836. Epub 2005 Oct 6.
6
Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs.
Biochem Biophys Res Commun. 2014 Jul 18;450(1):240-6. doi: 10.1016/j.bbrc.2014.05.102. Epub 2014 Jun 2.
10

引用本文的文献

2
Interpreting the Origins and Functions of Noncoding RNAs From the Ribosomal Genes.
J Cell Physiol. 2025 Aug;240(8):e70080. doi: 10.1002/jcp.70080.
3
Bypassing the guardian: regulated cell death pathways in p53-mutant cancers.
Cell Mol Biol Lett. 2025 Jun 14;30(1):68. doi: 10.1186/s11658-025-00751-5.
4
DEAD/H Box 5 (DDX5) Augments E2F1-Induced Cell Death Independent of the Tumor Suppressor p53.
Int J Mol Sci. 2024 Dec 10;25(24):13251. doi: 10.3390/ijms252413251.
5
Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression.
Biology (Basel). 2023 Dec 11;12(12):1511. doi: 10.3390/biology12121511.
6
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies.
MedComm (2020). 2023 May 28;4(3):e288. doi: 10.1002/mco2.288. eCollection 2023 Jun.
7
Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool.
Genes (Basel). 2023 Feb 2;14(2):393. doi: 10.3390/genes14020393.
8
Molecular Targeting of the Most Functionally Complex Gene in Precision Oncology: p53.
Cancers (Basel). 2022 Oct 22;14(21):5176. doi: 10.3390/cancers14215176.
9
The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy.
Front Oncol. 2022 Oct 20;12:1021609. doi: 10.3389/fonc.2022.1021609. eCollection 2022.
10
A unified model for the G1/S cell cycle transition.
Nucleic Acids Res. 2020 Dec 16;48(22):12483-12501. doi: 10.1093/nar/gkaa1002.

本文引用的文献

1
Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
Genes Dev. 2004 Jun 15;18(12):1413-22. doi: 10.1101/gad.1196704. Epub 2004 Jun 2.
2
Mdm2 regulates p53 independently of p19(ARF) in homeostatic tissues.
Mol Cell Biol. 2004 Jan;24(1):186-91. doi: 10.1128/MCB.24.1.186-191.2004.
3
Arf tumor suppressor promoter monitors latent oncogenic signals in vivo.
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15930-5. doi: 10.1073/pnas.2536808100. Epub 2003 Dec 9.
4
The tumor-suppressive functions of the human INK4A locus.
Cancer Cell. 2003 Oct;4(4):311-9. doi: 10.1016/s1535-6108(03)00223-x.
5
Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
Oncogene. 2003 Aug 7;22(32):4993-5005. doi: 10.1038/sj.onc.1206659.
6
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry.
Nature. 2003 Jul 10;424(6945):223-8. doi: 10.1038/nature01764.
7
Tumor suppression by Ink4a-Arf: progress and puzzles.
Curr Opin Genet Dev. 2003 Feb;13(1):77-83. doi: 10.1016/s0959-437x(02)00013-8.
8
ARF mutation accelerates pituitary tumor development in Rb+/- mice.
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16865-70. doi: 10.1073/pnas.262499599. Epub 2002 Dec 16.
9
p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation.
Curr Biol. 2002 Oct 29;12(21):1817-27. doi: 10.1016/s0960-9822(02)01225-3.
10
The RB and p53 pathways in cancer.
Cancer Cell. 2002 Aug;2(2):103-12. doi: 10.1016/s1535-6108(02)00102-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验